secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2022-11-08T23:59:59+00:00
Accession:  0001636422-22-000050
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst Q3 revenue $68.4M (+11% YoY), beats guidance; raises FY2022 outlook
--------------------------------------------------------------------------------

- Total revenue $68.4M (+11% YoY); technology revenue $43.9M (+15%), professional services $24.4M (+4%).
- GAAP net loss $45.7M; adjusted EBITDA loss $4.6M, improving 21% YoY.
- Raised full-year 2022 revenue and adjusted EBITDA guidance; dollar-based retention now expected 97-101%.
- CEO Dan Burton highlighted strong pipeline and cost reduction efforts ahead of schedule.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642222000050/0001636422-22-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642222000050/hcat-20221108.htm
  HTML page:      https://secwatch.observer/filing/0001636422-22-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer